Our partner is focused on developing treatments for rare genetic diseases, particularly lysosomal storage disorders. Their innovative therapies aim to address the underlying causes of these conditions, improving patient outcomes and quality of life.

This critical hire oversaw the development portfolio, led a team across Clinical Operations, Pharmacology, and Safety, and reported to the CMO. The role required full lifecycle drug development experience and strong leadership. Ideal candidates had experience in mid-sized companies, preferably in nephrology or cardiology.